These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1155379)

  • 1. Detection of mild factor VIII Deficiency by thrombokinetics.
    Natelson EA; Shapiro D; Smith DF
    Am J Clin Pathol; 1975 Jul; 64(1):95-100. PubMed ID: 1155379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):157-62. PubMed ID: 6603892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
    Baig MA; Swamy KB
    Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot waveform analysis in patients with haemophilia A.
    Siegemund T; Scholz U; Schobess R; Siegemund A
    Hamostaseologie; 2014; 34 Suppl 1():S48-52. PubMed ID: 25382770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.
    Matsumoto T; Nogami K; Shima M
    Int J Hematol; 2017 Feb; 105(2):174-183. PubMed ID: 27730530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple screening tests for the diagnosis of isolated clotting factor defects. With special reference to 'contact factor' defects.
    Ingram GI; Knights SF; Arocha-Piñango CL; Shepperd JP; Pérez-Requejo JL; Mills DK
    J Clin Pathol; 1975 Jul; 28(7):524-30. PubMed ID: 1080159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombinography: towards a globalization of coagulation tests].
    Péters P; Gothot A
    Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
    Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
    Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clotting time--an enigma resolved.
    Quick AJ
    Am J Clin Pathol; 1974 Nov; 62(5):670-2. PubMed ID: 4416126
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of the amount of thrombin generated in undiluted plasma during coagulation. Effect of platelets, thromboplastin, factor VIII and prothrombin complex.
    Triantaphyllopoulos DC
    Thromb Res; 1978 Dec; 13(6):915-29. PubMed ID: 155324
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated partial thromboplastin time. A multicenter evaluation of 11 reagents in the screening of mild haemophilia A.
    Scand J Haematol; 1980 Oct; 25(4):308-17. PubMed ID: 6782653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The partial thromboplastin time and factor VIII therapy.
    Bark CJ; Orloff MJ
    Am J Clin Pathol; 1972 Apr; 57(4):478-81. PubMed ID: 5012939
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined deficiency of factor V and factor VIII. A report of another case.
    Girolami A; Violante N; Cella G; Patrassi G
    Blut; 1976 Jun; 32(6):415-22. PubMed ID: 1276481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT.
    IDA M; TANAKA M
    Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory diagnosis of congenital coagulation defects.
    Lowe GD; Forbes CD
    Clin Haematol; 1979 Feb; 8(1):79-94. PubMed ID: 310747
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood coagulation and coagulation tests.
    Bennett JS
    Med Clin North Am; 1984 May; 68(3):557-76. PubMed ID: 6431207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.